Skip to main content
An official website of the United States government
Email

Dr. Wenyi Wang - Deciphering Cancer Cell Evolution and Ecology

Profile picture of a woman, Dr. Wenyi Wang

Dr. Wenyi Wang

February 23, 2023 | 10:30 AM – 11:30 AM

Zoom

Add to Outlook Calendar

Speaker

Wenyi Wang, Ph.D., Professor
Department of Bioinformatics and Computational Biology and Department of Biostatistics
The University of Texas 
MD Anderson Cancer Center

Title

Deciphering Cancer Cell Evolution and Ecology

Join the Meeting

Zoom

Abstract

In most cancers, the heterogeneity of cell composition within and between tumor samples is mirrored in complex variations at the molecular level. This molecular complexity includes both transcriptional variation (i.e., ecology) and genomic complexity (i.e., evolution) as tumors continually evolve and acquire new mutations. Therefore, to further our understanding of tumor evolution, it is essential to study the evolutionary dynamics between cancer genomes and transcriptomes. However, due to the complex interplay between cancer cells and their environments, these dynamics are still poorly understood, presenting a major bottleneck for the advancement of clinical management and treatment of cancer patients. Building on previous work in DeMixT for transcriptomic deconvolution, we have developed DeMix.SC, a new approach to deconvolve bulk RNA sequencing data using single-cell reference profiles. DeMix.SC is unique in taking advantage of a benchmark dataset to estimate systematic platform errors and specifically account for them during deconvolution. We will use a retina dataset to demonstrate improved deconvolution performance because of such adjustment. Furthermore, building on previous work in MuSE for subclonal somatic mutation calling, we have developed Clonal structure identification through pair-wise Penalization (CliP) to quantify the genomic dynamics. We found CliP is robust and accurate when applied to both whole genome (PCAWG, n = 1,993) and whole exome sequencing (TCGA, n = 7,711) data spanning >30 cancer types. The reconstructed tumor subclonality associates significantly with clinical subtypes and prognosis. In summary, quantitative measurement of heterogeneity in tissue samples at scale using multi-omics data remains an open and potentially impactful problem for the treatment of cancer and other diseases.

Host

Li C. Cheung, Ph.D., Earl Stadtman investigator
Biostatistics Branch

Email